中国组织工程研究
中國組織工程研究
중국조직공정연구
Journal of Clinical Rehabilitative Tissue Engineering Research
2014年
25期
4026-4031
,共6页
韩宏光%韩劲松%王辉山%方敏华%李波%李晓密%徐莉莹%孟庆涛
韓宏光%韓勁鬆%王輝山%方敏華%李波%李曉密%徐莉瑩%孟慶濤
한굉광%한경송%왕휘산%방민화%리파%리효밀%서리형%맹경도
生物材料%材料相容性%牛心包补片%心脏间隔缺损%修复%肺动脉高压%先天性心脏病%伊洛前列环素
生物材料%材料相容性%牛心包補片%心髒間隔缺損%脩複%肺動脈高壓%先天性心髒病%伊洛前列環素
생물재료%재료상용성%우심포보편%심장간격결손%수복%폐동맥고압%선천성심장병%이락전렬배소
pericardium%hypertension,pulmonary%heart diseases
背景:对于先天性心脏病合并肺动脉高压的治疗,传统降低肺动脉高压的药物效果确实,但存在不易监测、停药后反跳等现象;传统的心脏涤纶补片较易引起吻合口变形、血栓、栓塞、溶血和感染等并发症。目的:观察应用戊二醛处理牛心包补片和雾化吸入伊洛前列环素治疗先天性心脏病合并肺动脉高压的效果。方法:选择90例先天性心脏病合并肺动脉高压患者,术中采用戊二醛处理的牛心包补片修补心脏间隔缺损,术后雾化吸入伊洛前列环素30 ng/(min·kg),日间12 h按1次/4 h给药,夜间12 h按1次/6 h给药,连续给药2 d。记录每次吸入药物前、吸入后即刻、吸入30 min后平均动脉压、平均肺动脉压、体循环阻力指数与肺循环阻力指数,于随访期观察有无心包材料相关并发症和心功能情况。结果与结论:90例患者复查超声心动图见活瓣均已关闭,无分流,心脏间隔缺损无回声中断,心脏收缩功能正常,未发现与牛心包补片相关的不良反应。所有患者不同时间点平均动脉压、体循环阻力指数比较差异无显著性意义。患者吸入药物后即刻平均肺动脉压、肺循环阻力指数明显低于吸入药物前(P <0.01),吸入30 min后平均肺动脉压、肺循环阻力指数亦明显低于吸入药物前(P <0.05)。表明应用戊二醛处理的牛心包补片和雾化吸入伊洛前列环素治疗先天性心脏病合并肺动脉高压安全、有效。
揹景:對于先天性心髒病閤併肺動脈高壓的治療,傳統降低肺動脈高壓的藥物效果確實,但存在不易鑑測、停藥後反跳等現象;傳統的心髒滌綸補片較易引起吻閤口變形、血栓、栓塞、溶血和感染等併髮癥。目的:觀察應用戊二醛處理牛心包補片和霧化吸入伊洛前列環素治療先天性心髒病閤併肺動脈高壓的效果。方法:選擇90例先天性心髒病閤併肺動脈高壓患者,術中採用戊二醛處理的牛心包補片脩補心髒間隔缺損,術後霧化吸入伊洛前列環素30 ng/(min·kg),日間12 h按1次/4 h給藥,夜間12 h按1次/6 h給藥,連續給藥2 d。記錄每次吸入藥物前、吸入後即刻、吸入30 min後平均動脈壓、平均肺動脈壓、體循環阻力指數與肺循環阻力指數,于隨訪期觀察有無心包材料相關併髮癥和心功能情況。結果與結論:90例患者複查超聲心動圖見活瓣均已關閉,無分流,心髒間隔缺損無迴聲中斷,心髒收縮功能正常,未髮現與牛心包補片相關的不良反應。所有患者不同時間點平均動脈壓、體循環阻力指數比較差異無顯著性意義。患者吸入藥物後即刻平均肺動脈壓、肺循環阻力指數明顯低于吸入藥物前(P <0.01),吸入30 min後平均肺動脈壓、肺循環阻力指數亦明顯低于吸入藥物前(P <0.05)。錶明應用戊二醛處理的牛心包補片和霧化吸入伊洛前列環素治療先天性心髒病閤併肺動脈高壓安全、有效。
배경:대우선천성심장병합병폐동맥고압적치료,전통강저폐동맥고압적약물효과학실,단존재불역감측、정약후반도등현상;전통적심장조륜보편교역인기문합구변형、혈전、전새、용혈화감염등병발증。목적:관찰응용무이철처리우심포보편화무화흡입이락전렬배소치료선천성심장병합병폐동맥고압적효과。방법:선택90례선천성심장병합병폐동맥고압환자,술중채용무이철처리적우심포보편수보심장간격결손,술후무화흡입이락전렬배소30 ng/(min·kg),일간12 h안1차/4 h급약,야간12 h안1차/6 h급약,련속급약2 d。기록매차흡입약물전、흡입후즉각、흡입30 min후평균동맥압、평균폐동맥압、체순배조력지수여폐순배조력지수,우수방기관찰유무심포재료상관병발증화심공능정황。결과여결론:90례환자복사초성심동도견활판균이관폐,무분류,심장간격결손무회성중단,심장수축공능정상,미발현여우심포보편상관적불량반응。소유환자불동시간점평균동맥압、체순배조력지수비교차이무현저성의의。환자흡입약물후즉각평균폐동맥압、폐순배조력지수명현저우흡입약물전(P <0.01),흡입30 min후평균폐동맥압、폐순배조력지수역명현저우흡입약물전(P <0.05)。표명응용무이철처리적우심포보편화무화흡입이락전렬배소치료선천성심장병합병폐동맥고압안전、유효。
BACKGROUND:The treatment of pulmonary hypertension secondary to congenital heart disease has been a hot topic in the clinical research on cardiac surgery. Although traditional drugs for reducing pulmonary hypertension have excelent effects, there are some defaults, such as difficult monitoring and rebounding phenomenon after drug withdrawal. The traditional heart dacron graft is prone to cause complications, such as deformation, thrombosis, embolism, hemolysis and infection. OBJECTIVE:To investigate the effect of glutaraldehyde-fixed bovine pericardium patch and aerosolized iloprost in patients with pulmonary hypertension secondary to congenital heart disease. METHODS:Ninety patients with pulmonary hypertension due to congenital heart disease underwent a surgery. Glutaraldehyde-treated bovine pericardium patch were used to repair cardiac septal defect, and then aerosolized iloprost was applied after operation, administered for 3 days according to 30 ng/min/kg, every 4 hours in the first 12 hours of a day, and every 6 hours in the resting 12 hours. Mean arterial pressure, mean pulmonary arterial pressure, systemic vascular resistance index, pulmonary vascular resistance index were recorded before inhalation, immediately after inhalation, and 30 minutes after inhalation. The pericardium-associated complications, and cardiac function were also observed at folow-ups. RESULTS AND CONCLUSION: The involved 90 cases were detected by echocardiography. The results showed that, al the flaps were closed, there was no shunting or echo discontinuation of atrial septum. The heart contraction function was normal. No pericardium-associated complications were found. There was no significant difference in the mean arterial pressure and systemic vascular resistance index in al patients at different time points. The mean pulmonary arterial pressure and pulmonary vascular resistance index immediately after inhalation were significantly lower than that before inhalation (P < 0.01). The decrease was also significant 30 minutes after inhalation (P < 0.05). The intervention of glutaraldehyde-fixed bovine pericardium patch and aerosolized iloprost is safe and effective to treat patients with pulmonary hypertension secondary to congenital heart disease.